Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ikapharmindo Putramas Tbk. (IKPM) vs Prodia Diagnostic Line Tbk (PRDL) Price & Performance

Ikapharmindo Putramas Tbk.Trade
Prodia Diagnostic Line TbkTrade

Price performance (Past 24H)

Key statistics

Ikapharmindo Putramas Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 313.35B, 1.41M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp236 (market cap 428.75B, 13.83M 24h volume). The key difference: Prodia Diagnostic Line Tbk is the larger of the two by market cap, and Prodia Diagnostic Line Tbk is more actively traded (13.83M versus 1.41M). Which is the better fit depends on your goals.

IKPMPRDL
Market Cap
313.35B428.75B
Volume
1.41M13.83M
Lot
14.1K138.27K
Turnover
271.25M3.27B
Average Price
192.33236.62
Value
271.25M3.27B
Indicative Equilibrium Price
186236
Indicative Equilibrium Volume
6001.74K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

IKPM
View details
PRDL
View details

About Ikapharmindo Putramas Tbk.

PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.

Read more on IKPM

About Prodia Diagnostic Line Tbk

PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.

Read more on PRDL